Cargando…
A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma
N-propionyl-4-S-cysteaminylphenol (N-Pr-4-S-CAP) is a substrate for tyrosinase, which is a melanin biosynthesis enzyme and has been shown to be selectively incorporated into melanoma cells. It was found to cause selective cytotoxicity against melanocytes and melanoma cells after selective incorporat...
Autores principales: | Tamura, Yasuaki, Ito, Akira, Wakamatsu, Kazumasa, Torigoe, Toshihiko, Honda, Hiroyuki, Ito, Shosuke, Jimbow, Kowichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049105/ https://www.ncbi.nlm.nih.gov/pubmed/36982309 http://dx.doi.org/10.3390/ijms24065235 |
Ejemplares similares
-
Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review
por: Tamura, Yasuaki, et al.
Publicado: (2022) -
Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development
por: Wakamatsu, Kazumasa, et al.
Publicado: (2022) -
Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles
por: Jimbow, Kowichi, et al.
Publicado: (2013) -
Growth Inhibition of Re-Challenge B16 Melanoma Transplant by Conjugates of Melanogenesis Substrate and Magnetite Nanoparticles as the Basis for Developing Melanoma-Targeted Chemo-Thermo-Immunotherapy
por: Takada, Tomoaki, et al.
Publicado: (2009) -
Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma
por: Hida, Tokimasa, et al.
Publicado: (2020)